• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.61% Nasdaq Up 0.24%

    ArQule Inc. (ARQL)

    -NasdaqGM
    1.80 Up 0.03(1.69%) 4:00PM EDT
    Prev Close:1.77
    Open:1.76
    Bid:1.78 x 400
    Ask:1.80 x 7200
    1y Target Est:3.92
    Beta:1.2664
    Earnings Date:Nov 2 - Nov 7 (Est.)
    Day's Range:1.70 - 1.80
    52wk Range:1.37 - 2.65
    Volume:147,874
    Avg Vol (3m):99,803
    Market Cap:128.01M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARQLUp 1.69%128.01M
    ARRYDown 4.78%910.02M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.33
    Quarterly EPS Est (Sep-16) :-0.09
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-1.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met recepto... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback